Galaxy Surfactants Results Earnings Call for Q3FY24
Conference Call with Galaxy Surfactants Management and Analysts on Q3FY24 Performance and Outlook. Listen to the full earnings transcript.13-02-2024
Galaxy Surfactants Results Earnings Call for Q3FY24
Conference Call with Galaxy Surfactants Management and Analysts on Q3FY24 Performance and Outlook. Listen to the full earnings transcript.Galaxy Surfactants Ltd - 540935 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Duplicate share CertificateGalaxy Surfactants Ltd - 540935 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed Press release on Q3-FY 2023-24Galaxy Surfactants Ltd - 540935 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed Investor Presentation for Q3-2023-24Galaxy Surfactants Ltd - 540935 - Unaudited Financial Results (Consolidated And Standalone) Of The Company For The Quarter And Nine Months Ended December 31, 2023
Please find enclosed unaudited financial results for the quarter and nine months ended December 31, 2023.Galaxy Surfactants Ltd - 540935 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Duplicate CertificateGalaxy Surfactants Ltd - 540935 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analyst MeetingGalaxy Surfactants Ltd - 540935 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of Share CertificateGalaxy Surfactants Ltd - 540935 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analyst/ Investor Conference Call on February 13,2024 at 12 NoonGalaxy Surfactants Ltd - 540935 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results Of The Company (Consolidated And Standalone) For Quarter & Nine Months Ended December 31, 2023.
Galaxy Surfactants Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 ,inter alia, to consider and approve the Unaudited Financial Results of the Company (Consolidated and Standalone) for quarter & nine months ended December 31, 2023.